The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Stage 1 results of BrUOG 354: A randomized phase II trial of nivolumab alone or in combination with ipilimumab for people with ovarian and other extra-renal clear cell carcinomas (NCT03355976).
 
Don S. Dizon
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; i-Mab; Oasmia Pharmaceutical AB; Pfizer; Regeneron; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Kazia Therapeutics (Inst); Pfizer (Inst)
 
Katina Robison
No Relationships to Disclose
 
Shannon Diane MacLaughlan David
No Relationships to Disclose
 
Jason T Machan
No Relationships to Disclose
 
Matthew James Hadfield
No Relationships to Disclose
 
Eric I Marks
Honoraria - Brand Institute; M3; Medscape; Sermo
 
Rani Chudasama
No Relationships to Disclose
 
Tarra Evans
No Relationships to Disclose
 
Mary Lorraine Lopresti
No Relationships to Disclose
 
Emma Safran
No Relationships to Disclose
 
Michaela Kastura
No Relationships to Disclose
 
Faith Hassinger
No Relationships to Disclose
 
Ashlee Sturtevant
No Relationships to Disclose
 
Roxanne Wood
No Relationships to Disclose
 
Alexi A. Wright
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - NCCN/AstraZeneca (Inst); Pack Health (Inst)
 
Rochelle Strenger
No Relationships to Disclose
 
Ursula A. Matulonis
Honoraria - Advaxis; Alkermes; Symphogen
Consulting or Advisory Role - Agenus; AstraZeneca; Blueprint Medicines; GlaxoSmithKline; Merck; NextCure; Novartis; Trillium Therapeutics
Research Funding - Fujifilm; Immunogen; Leap Therapeutics; Merck; Mersana; Novartis; SQZ Biotech; Syndax; Tesaro
Travel, Accommodations, Expenses - AstraZeneca
 
Christina Bandera
No Relationships to Disclose
 
Susana M. Campos
Honoraria - AstraZeneca/Merck; Eisai
Consulting or Advisory Role - AstraZeneca/Merck; Eisai; GlaxoSmithKline
 
Michael J. Birrer
Consulting or Advisory Role - Acceleron Pharma; AstraZeneca/Merck; Clovis Oncology; ImmunoGen; Merrimack; Oxigene; Roche/Genentech; Sanofi; Tesaro; Threshold Pharmaceuticals